Vittorina Zagonel Selected Research

Colorectal Neoplasms (Colorectal Cancer)

4/2024	IMMUNOREACT 7: Regular aspirin use is associated with immune surveillance activation in colorectal cancer.
12/2023	Initial Panitumumab Plus Fluorouracil, Leucovorin, and Oxaliplatin or Plus Fluorouracil and Leucovorin in Elderly Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The PANDA Trial by the GONO Foundation.
1/2022	Case report: Complete pathologic response with first-line immunotherapy combination in a young adult with massive liver dissemination of mismatch repair-deficient metastatic colorectal cancer: Immunological and molecular profiling.
2/2021	Outcome of patients with colorectal cancer undergoing lung metastases resection: a single-institution retrospective analysis.
1/2021	Synaptophysin expression in V600EBRAF-mutated advanced colorectal cancers identifies a new subgroup of tumours with worse prognosis.
1/2021	The Pan-Immune-Inflammation Value in microsatellite instability-high metastatic colorectal cancer patients treated with immune checkpoint inhibitors.
1/2021	Detection of Molecular Residual Disease Using Personalized Circulating Tumor DNA Assay in Patients With Colorectal Cancer Undergoing Resection of Metastases.
1/2021	Prognostic impact of early tumor shrinkage and depth of response in patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors.
12/2020	Radiomics predicts response of individual HER2-amplified colorectal cancer liver metastases in patients treated with HER2-targeted therapy.
12/2020	Long-term Clinical Outcome of Trastuzumab and Lapatinib for HER2-positive Metastatic Colorectal Cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vittorina Zagonel Research Topics

Disease

77	Neoplasms (Cancer) 04/2024 - 01/2002
41	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 11/2008
33	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 12/2010
19	Disease Progression 01/2022 - 08/2013
16	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 01/2016
16	Glioma (Gliomas) 09/2021 - 12/2010
11	Neoplasm Metastasis (Metastasis) 04/2024 - 05/2012
11	Renal Cell Carcinoma (Grawitz Tumor) 12/2023 - 05/2011
11	Prostatic Neoplasms (Prostate Cancer) 03/2021 - 01/2015
8	Brain Neoplasms (Brain Tumor) 01/2023 - 01/2002
7	Adenocarcinoma 01/2022 - 08/2011
7	Colonic Neoplasms (Colon Cancer) 01/2020 - 10/2009
6	Microsatellite Instability 08/2023 - 11/2019
5	Carcinoma (Carcinomatosis) 10/2023 - 11/2019
5	Sarcoma (Soft Tissue Sarcoma) 02/2023 - 03/2016
5	Stomach Neoplasms (Stomach Cancer) 10/2021 - 01/2012
4	Rectal Neoplasms (Rectal Cancer) 04/2024 - 01/2019
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 02/2014
4	Fatigue 07/2021 - 06/2016
4	Neutropenia 01/2019 - 03/2003
4	Breast Neoplasms (Breast Cancer) 01/2018 - 03/2003
4	Ovarian Neoplasms (Ovarian Cancer) 01/2015 - 06/2008
3	Infections 01/2023 - 01/2021
3	Cholangiocarcinoma 01/2022 - 04/2017
3	Turcot syndrome 01/2021 - 01/2020
3	Edema (Dropsy) 01/2021 - 09/2013
3	Hypertension (High Blood Pressure) 07/2018 - 01/2013
2	Clinical Deterioration 01/2023 - 03/2012
2	Melanoma (Melanoma, Malignant) 02/2022 - 01/2014
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 01/2002
2	Leiomyosarcoma 01/2022 - 01/2020
2	Ependymoma 12/2021 - 01/2013
2	Circulating Neoplastic Cells 01/2021 - 01/2018
2	Hematologic Neoplasms (Hematological Malignancy) 12/2020 - 06/2003

Drug/Important Bio-Agent (IBA)

21	Bevacizumab (Avastin)FDA Link 02/2020 - 12/2010
18	Temozolomide (Temodar)FDA LinkGeneric 05/2022 - 08/2011
18	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 01/2011
14	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2013
11	regorafenibIBA 01/2022 - 01/2018
10	Immune Checkpoint InhibitorsIBA 02/2022 - 01/2018
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2012
9	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2023 - 10/2014
9	Fluorouracil (Carac)FDA LinkGeneric 12/2023 - 01/2014
9	Irinotecan (Camptosar)FDA LinkGeneric 02/2020 - 12/2010
7	Monoclonal AntibodiesIBA 01/2022 - 12/2010
7	Docetaxel (Taxotere)FDA Link 01/2021 - 01/2015
7	ErbB Receptors (EGF Receptor)IBA 01/2020 - 01/2012
6	Leucovorin (Folinic Acid)FDA Link 12/2023 - 01/2014
6	pembrolizumabIBA 01/2022 - 01/2018
6	Trastuzumab (Herceptin)FDA Link 12/2020 - 01/2011
5	Panitumumab (Vectibix)FDA Link 12/2023 - 06/2016
5	NivolumabIBA 01/2023 - 01/2022
5	Cetuximab (Erbitux)FDA Link 11/2021 - 11/2015
5	Angiogenesis InhibitorsIBA 05/2020 - 01/2013
5	Capecitabine (Xeloda)FDA Link 01/2020 - 10/2009
5	fotemustine (Muphoran)IBA 12/2018 - 01/2014
4	Thyroid HormonesIBA 10/2023 - 01/2018
4	cabozantinibIBA 01/2023 - 07/2018
4	PlatinumIBA 01/2022 - 10/2009
4	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2012
4	Lomustine (CCNU)FDA Link 01/2021 - 01/2014
4	Lapatinib (GW572016)FDA Link 12/2020 - 11/2015
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2018 - 12/2010
3	IpilimumabIBA 01/2023 - 01/2022
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2023 - 05/2015
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2002
3	depatuxizumab mafodotinIBA 06/2021 - 01/2020
3	Sunitinib (Sutent)FDA Link 01/2021 - 06/2015
3	enzalutamideIBA 01/2021 - 07/2015
3	MicroRNAs (MicroRNA)IBA 01/2021 - 09/2013
3	Circulating Tumor DNAIBA 01/2021 - 01/2018
3	XELOXIBA 01/2020 - 11/2014
3	erucylphosphocholineIBA 07/2019 - 01/2016
3	Cisplatin (Platino)FDA LinkGeneric 02/2014 - 08/2011
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2024 - 01/2021
2	AntigensIBA 01/2023 - 11/2008
2	O-(6)-methylguanineIBA 05/2022 - 01/2002
2	MethyltransferasesIBA 05/2022 - 01/2002
2	VaccinesIBA 01/2022 - 01/2022
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2021
2	TrabectedinIBA 01/2022 - 01/2019
2	Protein Isoforms (Isoforms)IBA 10/2021 - 10/2021
2	Prednisone (Sone)FDA LinkGeneric 01/2021 - 01/2016
2	abirateroneIBA 01/2021 - 01/2015
2	pertuzumabIBA 12/2020 - 01/2020

Therapy/Procedure

53	Therapeutics 01/2023 - 03/2003
40	Drug Therapy (Chemotherapy) 12/2023 - 09/2002
19	Radiotherapy 01/2023 - 09/2002
14	Palliative Care (Palliative Therapy) 04/2024 - 12/2011
10	Immunotherapy 12/2023 - 01/2017
9	Castration 01/2021 - 01/2015
6	Chemoradiotherapy 05/2022 - 05/2015
6	Adjuvant Chemotherapy 12/2020 - 11/2014
4	Nutritional Support (Artificial Feeding) 01/2022 - 01/2016
3	Ambulatory Care (Outpatient Care) 02/2024 - 05/2016
3	Neoadjuvant Therapy 03/2023 - 02/2014
3	Aftercare (After-Treatment) 01/2022 - 01/2018
3	Precision Medicine 12/2020 - 01/2017
2	Combined Modality Therapy 09/2021 - 12/2020
2	Metastasectomy 02/2021 - 01/2019